Aspergillus IgM Antibody Test: Overview

The Aspergillus IgM antibody test detects IgM antibodies against Aspergillus species, a genus of fungi that can cause infections, particularly in immunocompromised individuals. This test is often used to support the diagnosis of acute invasive aspergillosis or allergic bronchopulmonary aspergillosis (ABPA) but has limited sensitivity and specificity.

Purpose of the Test

✅ Detect early or active Aspergillus infection (e.g., invasive pulmonary aspergillosis)
✅ Differentiate between colonization and active infection
✅ Support the diagnosis of allergic reactions to Aspergillus (e.g., ABPA)

Interpreting Results

🔹 False positives can occur due to cross-reactivity with other fungi.
🔹 False negatives are common, especially in immunocompromised patients who may not mount a strong IgM response.

Clinical Significance

• Invasive Pulmonary Aspergillosis (IPA) → A serious fungal infection in immunocompromised patients (e.g., chemotherapy, organ transplant, HIV/AIDS).

• Allergic Bronchopulmonary Aspergillosis (ABPA) → Hypersensitivity reaction in patients with asthma or cystic fibrosis.

• Aspergillus Colonization → Often found in chronic lung diseases (COPD, TB) but may not indicate active infection.

Additional Diagnostic Tests

✔ Aspergillus IgG → More reliable for chronic or past infection.
✔ Galactomannan Antigen Test → Preferred for invasive aspergillosis.
✔ Beta-D-Glucan Test → Detects fungal infections but not specific to Aspergillus.
✔ Fungal Culture & PCR → Direct identification from sputum, BAL (bronchoalveolar lavage), or biopsy.
✔ Chest CT Scan → May show characteristic “halo sign” or lung nodules in invasive aspergillosis.

Next Steps if Positive

🔹 Evaluate symptoms & risk factors (e.g., immunosuppression, lung disease).
🔹 Consider follow-up testing (IgG, galactomannan, fungal culture, imaging).
🔹 Start antifungal treatment if clinically indicated (e.g., voriconazole, amphotericin B for invasive disease).